Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0176 Transporter Info | ||||
Gene Name | SLC25A17 | ||||
Transporter Name | Peroxisomal membrane protein PMP34 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview ofSLC25A17 Modification Sites with Functional and Structural Information | |||||
Sequence | MASVLSYESL VHAVAGAVGS VTAMTVFFPL DTARLRLQVD EKRKSKTTHM VLLEIIKEEG
LLAPYRGWFP VISSLCCSNF VYFYTFNSLK ALWVKGQHST TGKDLVVGFV AGVVNVLLTT PLWVVNTRLK LQGAKFRNED IVPTNYKGII DAFHQIIRDE GISALWNGTF PSLLLVFNPA IQFMFYEGLK RQLLKKRMKL SSLDVFIIGA VAKAIATTVT YPLQTVQSIL RFGRHRLNPE NRTLGSLRNI LYLLHQRVRR FGIMGLYKGL EAKLLQTVLT AALMFLVYEK LTAATFTVMG LKRAHQH |
||||
PTM type |
X-Acetylation
X-Phosphorylation
X-Ubiquitination
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Lysine | 1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A17 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
130 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A17 Lysine 130 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A17 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
20 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Serine 20 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A17 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
228 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Serine 228 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A17 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
246 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Serine 246 has the potential to affect its expression or activity. | ||||
Threonine | 3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
Have the potential to influence SLC25A17 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
292 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Threonine 292 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
Have the potential to influence SLC25A17 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
295 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Threonine 295 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
Have the potential to influence SLC25A17 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
297 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A17 Threonine 297 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine | 4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon1 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
95 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A17 Lysine 95 has the potential to affect its expression or activity. | ||||
PTM Phenomenon2 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
95 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A17 Lysine 95 has the potential to affect its expression or activity. | ||||
PTM Phenomenon3 |
. | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
95 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A17 Lysine 95 has the potential to affect its expression or activity. | ||||
PTM Phenomenon4 |
Have the potential to influence SLC25A17 | [5], [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
268 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A17 Lysine 268 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.